A taxonomy of estimands for regulatory clinical trials with discontinuations

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Statistics in Medicine

• Publication date

  2016-07-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/sim.6841PMID 26678026
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The handling of missing data in clinical trials

  2013cited by this paper
• The prevention and treatment of missing data in clinical trials.

  2012cited by this paper
• Targeted Learning: Causal Inference for Observational and Experimental Data

  2011cited by this paper
• Direct Effects and Effect Among the Treated

  2011cited by this paper
• Alternative Graphical Causal Models and the Identification of Direct E!ects

  2010cited by this paper
• Some Topics in Missing Data and Adaptive Confidence Intervals. Some Topics in Missing Data and Adaptive Confidence Intervals.

  2009cited by this paper
• On Identification and Inference for Direct Effects

  2009cited by this paper
• A Note on Stratification in Clinical Trials

  2007cited by this paper
• Use of the cumulative proportion of responders analysis graph to present pain data over a range of cut-off points: making clinical trial data more understandable.

  2006cited by this paper
• Continuous indices of core data set measures in rheumatoid arthritis clinical trials: lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteria.

  2005cited by this paper
• A test for the difference between two treatments in a continuous measure of outcome when there are dropouts.

  1992cited by this paper
• On the Application of Probability Theory to Agricultural Experiments. Essay on Principles. Section 9

  1990cited by this paper
• A new approach to the analysis of clinical drug trials with withdrawals.

  1980cited by this paper
• Estimating causal effects of treatments in randomized and nonrandomized studies.

  1974cited by this paper
• Statistical Methods for Research Workers

  1937cited by this paper

• A Tipping Point Method to Evaluate Sensitivity to Potential Violations in Missing Data Assumptions

  2025cites this paper
• Clinical and Statistical Perspectives on the ICH E9(R1) Estimand Framework Implementation

  2023cites this paper
• Time to deterioration of symptoms or function using patient-reported outcomes in cancer trials.

  2022cites this paper
• A likely responder approach for the analysis of randomized controlled trials.

  2022cites this paper
• Estimation of treatment effects in short‐term depression studies. An evaluation based on the ICH E9(R1) estimands framework

  2022cites this paper
• Estimands: bringing clarity and focus to research questions in clinical trials

  2022cites this paper
• Estimating the treatment effect for adherers using multiple imputation

  2021cites this paper
• M E ] 2 2 N ov 2 02 1 1 Monotonicity assumptions in estimating the treatment effect for a principal stratum

  2021cites this paper
• SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials

  2021cites this paper
• Statistical Inference on the Estimators of the Adherer Average Causal Effect

  2021cites this paper
• Estimands for Recurrent Event Endpoints in the Presence of a Terminal Event

  2021cites this paper
• A novel estimand to adjust for rescue treatment in randomized clinical trials

  2021cites this paper
• Assessing the Commonly Used Assumptions in Estimating the Principal Causal Effect in Clinical Trials

  2021cites this paper
• Two-level approaches to missing data in longitudinal trials with daily patient-reported outcomes

  2020cites this paper
• Essential statistical principles of clinical trials of pain treatments

  2020cites this paper
• Choosing Estimands in Clinical Trials: Putting the ICH E9(R1) Into Practice

  2020cites this paper
• Biostatistics in Clinical Trials

  2020cites this paper
• Estimands and Sensitivity Analyses

  2020cites this paper
• Demystifying the estimand framework: a case study using patient-reported outcomes in oncology.

  2020cites this paper
• A novel estimand to adjust for rescue treatment in clinical trials

  2020cites this paper
• Causal Inference and Estimands in Clinical Trials

  2020cites this paper
• A General Framework for Treatment Effect Estimators Considering Patient Adherence

  2020cites this paper
• Defining estimands using a mix of strategies to handle intercurrent events in clinical trials

  2020cites this paper
• Implementation of tripartite estimands using adherence causal estimators under the causal inference framework

  2020cites this paper
• Estimands and missing data in clinical trials of chronic pain treatments: advances in design and analysis.

  2020cites this paper
• Model Averaging Using Likelihoods That Reflect Poor Outcomes for Clinical Trial Dropouts

  2020cites this paper
• Statistics at FDA: Reflections on the Past Six Years

  2019cites this paper
• A causal modelling framework for reference-based imputation and tipping point analysis in clinical trials with quantitative outcome

  2019cites this paper
• Choosing Estimands in Clinical Trials: Putting the ICH E9(R1) Into Practice.

  2019cites this paper
• Incorporating and interpreting regulatory guidance on estimands in diabetes clinical trials: The PIONEER 1 randomized clinical trial as an example

  2019cites this paper
• Bayesian inference for a principal stratum estimand to assess the treatment effect in a subgroup characterized by postrandomization event occurrence

  2019cites this paper
• Estimands and inference in cluster‐randomized vaccine trials

  2019cites this paper
• Assessing the ratio of means as a causal estimand in clinical endpoint bioequivalence studies in the presence of intercurrent events

  2019influential citation
• Covariate adjustment for randomized controlled trials revisited

  2019cites this paper
• Choose to Lead

  2019cites this paper
• Choosing Measures of Treatment Benefit: Estimands and Beyond

  2019cites this paper
• Estimation of causal effects in clinical endpoint bioequivalence studies in the presence of intercurrent events: noncompliance and missing data

  2018cites this paper
• Bayesian inference for a principal stratum estimand to assess the treatment effect in a subgroup characterized by post-randomization events

  2018cites this paper
• Assessing the influence of treatment nonadherence on noninferiority trials using the tipping point approach

  2018cites this paper
• Estimands: improving inference in randomized controlled trials in clinical nutrition in the presence of missing values

  2018cites this paper
• Points to consider for analyzing efficacy outcomes in long‐term extension clinical trials

  2018cites this paper
• Estimands and Their Role in Clinical Trials

  2017influential citation
• Let's Go to the Videotape: Promoting the visibility and understanding of regulatory science by using case studies from publicly available FDA information

  2017cites this paper
• Estimands in clinical trials – broadening the perspective

  2017cites this paper
• Trimmed means for symptom trials with dropouts

  2017cites this paper
• Treatment of missing data in follow-up studies of randomised controlled trials: A systematic review of the literature

  2017cites this paper
• Control-Based Imputation and Delta-Adjustment Stress Test for Missing Data Analysis in Longitudinal Clinical Trials

  2017cites this paper
• Principal stratification : applications and extensions in clinical trials with intermediate variables

  2017influential citation
• Missing data in clinical trials: control‐based mean imputation and sensitivity analysis

  2017cites this paper
• Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes: The SWITCH 1 Randomized Clinical Trial

  2017cites this paper
• Considerations for Evaluating Treatment Effects From Randomized Clinical Trials

  2017cites this paper
• A causal modelling framework for reference-based imputation and tipping point analysis

  2017cites this paper
• Comments on “A taxonomy of estimands for regulatory clinical trials with discontinuations”

  2017influential citation
• Disentangling estimands and the intention‐to‐treat principle

  2017cites this paper
• Choosing estimands in clinical trials with missing data

  2017cites this paper
• Model‐Based Approach for Optimizing Study Design and Clinical Drug Performances of Extended‐Release Formulations of Methylphenidate for the Treatment of ADHD

  2017cites this paper
• A Meta-Analysis of Missing Data and Non-Compliance Data in Clinical Endpoint Bioequivalence Studies

  2016cites this paper
• Should multiple imputation be the method of choice for handling missing data in randomized trials?

  2016cites this paper
• Comments on the three papers by the FDA/CDER research team on the regulatory perspective of the missing data problem

  2016cites this paper
• Commentary for the Missing Data Working Group's perspective for regulatory clinical trials, estimands, and sensitivity analyses

  2016influential citation